Core Viewpoint - Recent collective interest rate cuts by major banks in China are driven by various economic factors, impacting both savings and borrowing behaviors in the economy [1][3]. Group 1: Reasons for Rate Cuts - The decline in yields of wealth management products and government bonds is a significant factor, with government bond rates dropping by 0.15 percentage points in September [3]. - Increased savings willingness among residents, driven by economic uncertainties, has led to a surge in household deposits, with a notable increase of 10 trillion yuan in the first half of 2022 [3]. - The primary goal of lowering deposit rates is to alleviate pressure on the real economy, providing lower financing costs for businesses and easing mortgage burdens for homebuyers [5]. Group 2: Impacts on Daily Life - Reduced interest income from deposits is expected, exemplified by a decrease in the three-year fixed deposit rate from 2.75% to 2.60%, resulting in a loss of 1,500 yuan in interest for a 1 million yuan deposit [8]. - Lower mortgage rates, now around 4.25% compared to over 5.8% last year, will benefit homebuyers, although existing borrowers may have to wait until early next year for new rates [10]. - Inflationary pressures may persist due to increased consumer spending and lower loan rates, suggesting that demand-side inflation could remain a concern in the coming years [10].

Meeting Overview - The first temporary shareholders' meeting of the company for 2025 was held on November 28, 2025, in Changsha, Hunan Province [2] - The meeting was conducted with a combination of on-site and online voting, presided over by Chairman Xie Zilong, and complied with relevant laws and regulations [2][3] Attendance - All 8 current directors attended the meeting, while Director Liu Xiaoen submitted a resignation report on November 27, 2025, due to personal work reasons [3] - All 3 current supervisors and the board secretary attended the meeting, along with some other senior executives [3] Resolutions Passed - Several resolutions were approved, including: - Change of registered capital and amendment of the Articles of Association [4] - Revision of the Rules of Procedure for Shareholders' Meetings [4] - Revision of the Rules of Procedure for Board Meetings [5] - Revision of the Management Measures for Related Transactions [5] - Revision of the Management Measures for External Investments [5] - Revision of the Management System for Raised Funds [5] - Revision of the Management System for External Donations [5] Legal Verification - The meeting was witnessed by Hunan Qiyuan Law Firm, confirming that the meeting's procedures and voting were in compliance with legal requirements [5] Director Resignation and Election - Director Liu Xiaoen's resignation took effect upon delivery of his written report, and it will not affect the board's minimum member count or the company's operations [6][7] - On November 28, 2025, the company held a staff representative meeting to elect Tan Jian as the staff representative director, effective until the end of the current board's term [6][7] New Director Profile - Tan Jian, born in 1977, holds a bachelor's degree in Traditional Chinese Medicine and an MBA. He has been with the company since 2008 and has held various positions, including staff representative supervisor and chairman of the supervisory board [10]

Core Viewpoint - The company announced the election of Mr. Tan Jian as the employee director of the fifth board of directors, with the term starting from November 28, 2025, until the end of the board's term [2] Summary by Sections - Announcement Details - The company will hold an employee representative meeting on November 28, 2025, to elect Mr. Tan Jian as the employee director [2]

证券代码：603883 证券简称：老百姓 公告编号：2025-067 公司分别于 2025 年 10 月 28 日、2025 年 11 月 28 日召开第五届董事会第十 一次会议和 2025 年第一次临时股东大会，审议通过了《关于变更注册资本并修 订<公司章程>的议案》，公司不再设置监事会，董事会成员包含一名职工代表董 事。 公司于 2025 年 11 月 28 日召开职工代表大会，选举谭坚先生担任公司第五 届董事会职工董事，任期自 2025 年 11 月 28 日起至公司第五届董事会任期届满 之日止。 一、董事/高级管理人员离任情况 | 姓名 | 离任职务 | 离任时间 | 原定任期 | 离任原因 | 是否继续在上 市公司及其控 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | | 股子公司任职 | （如适用） | 毕的公开 | | | | | | | | | 承诺 | | 刘晓恩 | 董事 | 2025 年 11 | 2027 年 2 月 | 个人工作 | 否 | 不适用 | 否 | | ...

证券代码：603883 证券简称：老百姓 公告编号：2025-066 老百姓大药房连锁股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 11 月 28 日 (二)股东大会召开的地点：湖南省长沙市开福区青竹湖路 808 号老百姓 15 楼会 议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 593 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 371,553,471 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 48.9601 | | 份总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议采取现场投票和网络投票相结合的方式召开，老百姓大药房连锁股份有 限公司（以下简称"公司"）董事会召集本次会 ...

湖南启元律师事务所 关于老百姓大药房连锁股份有限公司 2025年第一次临时股东大会的 法律意见书 二零二五年十一月二十八日 湖南启元律师事务所（以下简称"本所"）接受老百姓大药房连锁股份有限 公司（以下简称"公司"）的委托，指派律师出席了公司 2025 年第一次临时股东 大会（以下简称"本次股东大会"），对本次股东大会的召集和召开程序、出席 会议人员及召集人的资格、表决程序和表决结果的合法有效性进行律师见证，并 发表本法律意见。 本所根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以 下简称"《股东会规则》"）等我国现行法律、法规、规范性文件以及《老百姓 大药房连锁股份有限公司章程》（以下简称"《公司章程》"）的有关规定出具 本法律意见书。 为出具本法律意见书，本所声明如下： （一）本所出具本法律意见书是基于公司已承诺所有提供给本所的文件的正 本以及经本所查验与正本保持一致的副本均为真实、完整、可靠，无隐瞒、虚假 或重大遗漏之处。 （二）本所遵循了勤勉尽责和诚实信用原则，严格履行了法定职责，对本法 律意见书出具日以前已经发生 ...

熬个夜第二天就心慌；吃个火锅就拉肚子；办公室坐一天浑身酸痛……这是不是你的生活日常？ 眼下，越来越多人用"脆皮"自嘲。有人是"职场萌新脆"，爆痘与胃痛是常态；有人荣升"顶梁柱脆"，失眠与腰酸如影随形；还有人纯属"天生脆皮"，小病 小痛见缝插针。 可以说，健康的人总是相似的，"脆皮"人却各有各的小毛病。 近期，第一财经商业数据中心（CBNData）发布的《"脆皮"潮下的健康突围 ACE止脆方案》（以下简称《方案》）*显示：认为自己自带"脆皮"属性的受 访者，占比高达96%。 在习惯、情绪、环境的三重夹击下，88%的人开始选择用药品、健康消费品等健康类产品积极自救。当健康成为价值观、世界观、人生观之外的"第四 观"，年轻人正在用一套全新的逻辑，认真管理起自己的身体。 吃药可社交？ 凌晨1点，25岁的设计师小林在完成方案后，选择提前一小时服下感冒药。她在社交平台发帖，"大夫让我8点吃药，我7点吃。给病毒来个出其不意"。 人们除了在评论区调侃她"这是给身体来把高端局"外，还讨论起提高免疫力的健康消费产品和效果。如今，年轻人不再盲目听从单一权威的教育，而是构 建着多元验证的健康信息决策体系。 这套决策逻辑的第一个环节， ...

Core Viewpoint - The Chinese government is implementing policies to enhance the adaptability of consumer goods supply and demand, aiming to promote consumption by aligning production with consumer preferences [1] Group 1 - The government encourages enterprises to understand and produce what consumers want, ensuring that products meet market demand and quality standards [1] - The initiative aims to provide consumers with satisfactory products and services, which in turn benefits businesses by ensuring their products are well-suited for the market [1]

Core Viewpoint - The Chinese government is implementing policies to enhance the adaptability of supply and demand in consumer goods, aiming to better align production with consumer preferences and improve service quality [2]. Group 1: Policy Measures - The government encourages enterprises to understand and produce what consumers want, ensuring that products are suitable and of high quality [2]. - The focus is on guiding companies to innovate and meet the demands of consumers, which will ultimately benefit both consumers and businesses [2].

Core Viewpoint - The demand for respiratory disease-related medications and protective supplies has significantly increased as respiratory diseases like influenza and mycoplasma pneumonia enter a high incidence season in China [2][3]. Group 1: Market Demand and Supply - The China Disease Prevention and Control Center has reported an upward trend in influenza cases, with sentinel hospitals in southern provinces reporting a percentage of influenza-like cases at 6.7% and northern provinces at 7.0% during the 46th week of 2025, indicating an earlier onset of the flu season compared to previous years [2]. - The company, Lao Bai Xi Da Yao Fang, has leveraged its nationwide supply chain and store network to ensure stable supply and price stability for four categories of medications, including antiviral drugs, antipyretics, cough suppressants, and antibiotics, as well as protective supplies like masks [2][3]. Group 2: Sales Performance - Sales of antiviral medications such as Oseltamivir and Mabalaoshuai (Sufuda), as well as antibiotics like Amoxicillin and Azithromycin, have seen significant growth recently, particularly in November, with a notable increase in sales of flu medications [3]. - The company has implemented a supply guarantee plan in anticipation of seasonal demand fluctuations, which includes early forecasting, centralized procurement, and increased stock levels to ensure market supply stability [3]. Group 3: Health Recommendations - The China Disease Prevention and Control Center has noted an increase in reported influenza outbreaks, particularly among children aged 5 to 14, and has recommended health monitoring in key institutions such as schools and nursing homes [4]. - The company emphasizes the importance of following medical advice for flu prevention and treatment, including vaccination, medication adherence, mask-wearing, hand hygiene, and environmental disinfection [4].